122 related articles for article (PubMed ID: 23148625)
41. ALCAM (CD166) expression and serum levels in pancreatic cancer.
Tachezy M; Zander H; Marx AH; Stahl PR; Gebauer F; Izbicki JR; Bockhorn M
PLoS One; 2012; 7(6):e39018. PubMed ID: 22745698
[TBL] [Abstract][Full Text] [Related]
42. Modulation of activated leukocyte cell adhesion molecule-mediated invasion triggers an innate immune gene response in melanoma.
van Kilsdonk JW; Takahashi N; Weidle U; Burtscher H; Jarry J; Daha MR; Swart GW; van Kempen LC
J Invest Dermatol; 2012 May; 132(5):1462-70. PubMed ID: 22318386
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma.
Pei L; Xie P; Zhou E; Yang Q; Luo Y; Tang Z
Mol Med Rep; 2011; 4(5):817-23. PubMed ID: 21643629
[TBL] [Abstract][Full Text] [Related]
44. ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.
Ferragut F; Vachetta VS; Troncoso MF; Rabinovich GA; Elola MT
Cytokine Growth Factor Rev; 2021 Oct; 61():27-37. PubMed ID: 34272152
[TBL] [Abstract][Full Text] [Related]
45. Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes.
Rauch SJ; Rosenkranz AC; Böhm A; Meyer-Kirchrath J; Hohlfeld T; Schrör K; Rauch BH
Vascul Pharmacol; 2011; 54(3-6):93-9. PubMed ID: 21440089
[TBL] [Abstract][Full Text] [Related]
46. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential 'Seed' and 'Soil' Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers.
Yang YM; Ye L; Ruge F; Fang Z; Ji K; Sanders AJ; Jia S; Hao C; Dou QP; Ji J; Jiang WG
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614319
[TBL] [Abstract][Full Text] [Related]
47. uPA receptor expression in benign and malignant thyroid tumors.
Kim SJ; Shiba E; Taguchi T; Tsukamoto F; Miyoshi Y; Tanji Y; Takai S; Noguchi S
Anticancer Res; 2002; 22(1A):387-93. PubMed ID: 12017319
[TBL] [Abstract][Full Text] [Related]
48. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.
van Kempen LC; van den Oord JJ; van Muijen GN; Weidle UH; Bloemers HP; Swart GW
Am J Pathol; 2000 Mar; 156(3):769-74. PubMed ID: 10702391
[TBL] [Abstract][Full Text] [Related]
49. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin.
Tomita K; van Bokhoven A; Jansen CF; Bussemakers MJ; Schalken JA
Biochem Biophys Res Commun; 2000 Jan; 267(3):870-4. PubMed ID: 10673383
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
[TBL] [Abstract][Full Text] [Related]
51. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.
Ihnen M; Köhler N; Kersten JF; Milde-Langosch K; Beck K; Höller S; Müller V; Witzel I; Jänicke F; Kilic E
Dis Markers; 2010; 28(2):71-8. PubMed ID: 20364042
[TBL] [Abstract][Full Text] [Related]
52. Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule.
van Kilsdonk JW; Wilting RH; Bergers M; van Muijen GN; Schalkwijk J; van Kempen LC; Swart GW
Cancer Res; 2008 May; 68(10):3671-9. PubMed ID: 18483249
[TBL] [Abstract][Full Text] [Related]
53. MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule).
Degen WG; van Kempen LC; Gijzen EG; van Groningen JJ; van Kooyk Y; Bloemers HP; Swart GW
Am J Pathol; 1998 Mar; 152(3):805-13. PubMed ID: 9502422
[TBL] [Abstract][Full Text] [Related]
54. Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.
Swart GW
Eur J Cell Biol; 2002 Jun; 81(6):313-21. PubMed ID: 12113472
[TBL] [Abstract][Full Text] [Related]
55. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
Ihnen M; Kress K; Kersten JF; Kilic E; Choschzick M; Zander H; Müller V; Mahner S; Jänicke F; Woelber L; Milde-Langosch K
BMC Cancer; 2012 Apr; 12():140. PubMed ID: 22475274
[TBL] [Abstract][Full Text] [Related]
56. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
57. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
[TBL] [Abstract][Full Text] [Related]
58. Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism.
Yang Y; Sanders AJ; Ruge F; Dong X; Cui Y; Dou QP; Jia S; Hao C; Ji J; Jiang WG
Am J Cancer Res; 2021; 11(12):5917-5932. PubMed ID: 35018233
[TBL] [Abstract][Full Text] [Related]
59. The Occurrence of Activated Leukocyte Cell Adhesion Molecule (ALCAM) and Its Predictive Factors in Patients with Oral Squamous Cell Carcinoma.
Motahhari P; Ghanadan A; Mirmohammadkhani M; Mansori K; Mirmohammadkhani O
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3735-3741. PubMed ID: 36444586
[TBL] [Abstract][Full Text] [Related]
60. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]